title: Role of bacterial DNA in macrophage activation by group B streptococci.
abstract: Bacterial DNA (CpG DNA) induces macrophage activation and the production of inflammatory mediators, including tumor necrosis factor (TNF) and nitric oxide (NO) by these cells. However, the role of bacterial DNA in the macrophage response to whole bacteria is unknown. We used overlapping strategies to estimate the relative contribution of bacterial DNA to the upregulation of TNF and NO production in macrophages stimulated with antibiotic-treated group B streptococci (GBS). Selective inhibitors of the bacterial DNA/TLR9 pathway (chloroquine, an inhibitory oligonucleotide, and DNase I) consistently inhibited GBS-induced TNF secretion by 35-50% in RAW 264.7 macrophages and murine splenic macrophages, but had no effect on inducible nitric oxide synthase (iNOS) accumulation or NO secretion. Similarly, splenic and peritoneal macrophages from mice lacking TLR9 expression secreted 40% less TNF than macrophages from control mice after GBS challenge but accumulated comparable amounts of iNOS protein. Finally, studies in both RAW 264.7 cells and macrophages from TLR9-/- mice implicated GBS DNA in the upregulation of interleukins 6 (IL-6) and 12 (IL-12) but not interferon-beta (IFNbeta), a key intermediary in macrophage production of iNOS/NO. Our data suggest that the bacterial DNA/TLR9 pathway plays an important role in stimulating TNF rather than NO production in macrophages exposed to antibiotic-treated GBS, and that TLR9-independent upregulation of IFNbeta production by whole GBS may account for this difference.
authors.affiliation: Department of Pediatrics, The University of Tennessee Health Science Center, Memphis, TN 38163, USA. atalati@utmem.edu
authors.forename: Ajay J
authors.initials: AJ
authors.lastname: Talati
authors.forename: Hae Jong
authors.initials: HJ
authors.lastname: Kim
authors.forename: Young-In
authors.initials: YI
authors.lastname: Kim
authors.forename: Ae-Kyung
authors.initials: AK
authors.lastname: Yi
authors.forename: B Keith
authors.initials: BK
authors.lastname: English
mesh_terms: D000818:Animals; D002738:Chloroquine / Q000494:pharmacology; D018899:CpG Islands; D016207:Cytokines / Q000378:metabolism; D004269:DNA, Bacterial / Q000502:physiology*; D003850:Deoxyribonuclease I / Q000378:metabolism; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology / Q000378:metabolism; D017737:Macrophages, Peritoneal / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D009569:Nitric Oxide / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013154:Spleen / Q000166:cytology; D013292:Streptococcus agalactiae / Q000235:genetics* / Q000276:immunology*; D051217:Toll-Like Receptor 9 / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D016207:Cytokines; D004269:DNA, Bacterial; C495370:Tlr9 protein, mouse; D051217:Toll-Like Receptor 9; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide; D002738:Chloroquine; D052247:Nitric Oxide Synthase Type II; D003850:Deoxyribonuclease I